Moderna begins COVID vaccine trials among children under 12
Health
- 17 March, 2021
- 06:18
The US company Moderna has started a new phase of its coronavirus vaccine trials, Report informs with reference to Interfax.
At this stage, the drug’s effectiveness will be tested on children aged from six months to 12 years.
The first trial participants aged six months to 12 years have received a dose of the jab.
The company says that the clinical trials in this age group will be carried out among “healthy children in the US and Canada.”
During this stage, the specialists intend to “assess the safety, tolerability, reactogenicity, and efficacy of two doses of the mRNA-1273 vaccine, which are administered with 28 days interval.
Latest News
12:35
President Ilham Aliyev congratulates Austrian Federal President on national holiday
Foreign policy12:07
Argentines vote in high-stakes test of Milei's libertarian vision
Other countries11:58
Azerbaijan's Ministry of Foreign Affairs congratulates Austria
Foreign policy11:44
JAXA launches new cargo spacecraft to International Space Station
Other countries11:11
European Union among top three trade partners of Russia
Other countries10:47
Israeli defense minister says 60% of Hamas tunnels are still intact
Other countries10:41
Rubio rejects US abandoning Taiwan for China deal
Other countries10:12
Vietnam appoints first female Deputy Prime Minister
Other countries09:55